| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:27153964:1158 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:27153964:1158?format=raw |
LEADER: 01158cam a2200289 4500
001 4026237
005 20221027021323.0
008 710920s1970 fi b 000 0 eng
010 $a 70593157
015 $aFi***
035 $a(OCoLC)ocm00198624
035 $9AJY4442HS
035 $a4026237
040 $aDLC$cDLC$dZCH
050 00 $aRM666.D57$bV58
100 1 $aViukari, N. Matti A.
245 10 $aDiphenylhydantoin in the treatment of mentally subnormal epileptics :$bconcentrations of diphenylhydantoin in serum and cerebrospinal fluid and the main electroytes /$cby N. Matti A. Viukari.
260 $aHelsinki :$bDepartment of Neurology, University of Helsinki,$c1970.
300 $a68 pages ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
502 $aThesis--Helsinki.
500 $aAt head of title: Rinnekoti Institute for the Mentally Retarded, Majalampi, Finland.
504 $aBibliography: p. 60-68.
650 0 $aPhenytoin.$0http://id.loc.gov/authorities/subjects/sh85100701
650 0 $aEpilepsy$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh2008119833
852 00 $boff,hsl$hRM666.D57$iV83 1970